{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:28:29Z","timestamp":1784298509369,"version":"3.55.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Cardiovascular Quality and Outcomes"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>\n              Days at home (DAH) represents an important patient-oriented outcome that quantifies time spent at home after a medical event; however, this outcome has not been fully evaluated for low-surgical-risk patients undergoing transcatheter aortic valve replacement (TAVR). We sought to compare 1- and 2-year DAH (DAH\n              <jats:sub>365<\/jats:sub>\n              and DAH\n              <jats:sub>730<\/jats:sub>\n              ) among low-risk patients participating in a randomized trial of TAVR with a self-expanding bioprosthesis versus surgical aortic valve replacement (SAVR).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>\n              Using Medicare-linked data from the Evolut Low Risk trial, we identified 619 patients: 606 (322 TAVR\/284 SAVR) and 593 (312 TAVR\/281 SAVR) were analyzed at 1 and 2 years, respectively. DAH was calculated as days alive and spent outside a hospital, inpatient rehabilitation, skilled nursing facility, long-term acute care hospital, emergency department, or observation stay. Mean DAH was compared using the\n              <jats:italic>t<\/jats:italic>\n              test.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>\n              The mean (SD) age and female sex were 74.7 (5.1) and 74.3 (4.9) years and 34.6% (115\/332) and 30.3% (87\/287) in TAVR and SAVR, respectively. Postprocedural discharge to rehabilitation occurred in \u22643.0% (\u226410\/332) in TAVR and 4.5% (13\/287) in SAVR. The mean DAH\n              <jats:sub>365<\/jats:sub>\n              was comparable in TAVR versus SAVR (352.2\u00b145.4 versus 347.8\u00b139.0; difference in days, 4.5 [95% CI, 2.3\u201311.2];\n              <jats:italic>P<\/jats:italic>\n              =0.20). DAH\n              <jats:sub>730<\/jats:sub>\n              was also comparable in TAVR versus SAVR (701.6\u00b1106.0 versus 699.6\u00b194.5; difference in days, 2.0 [\u221214.1 to 18.2];\n              <jats:italic>P<\/jats:italic>\n              =0.81). Secondary outcomes DAH\n              <jats:sub>30<\/jats:sub>\n              and DAH\n              <jats:sub>90<\/jats:sub>\n              were higher in TAVR (DAH\n              <jats:sub>30<\/jats:sub>\n              , 26.0\u00b13.6 versus 20.7\u00b16.4; difference in days, 5.3 [4.5\u20136.2];\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001; DAH\n              <jats:sub>90<\/jats:sub>\n              , 85.1\u00b18.3 versus 78.7\u00b113.6; difference in days, 6.4 [4.6\u20138.2];\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In the Evolut Low Risk trial linked to Medicare, low-risk patients undergoing TAVR spend a similar number of days at home at 1 and 2 years compared with SAVR. Days spent at home at 30 and 90 days were higher in TAVR. In contrast to higher-risk patients studied in prior work, there is no clear advantage of TAVR versus SAVR for DAH in the first 2 years after AVR in low-surgical-risk patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circoutcomes.123.010034","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T10:01:53Z","timestamp":1702375313000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Days at Home After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients"],"prefix":"10.1161","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-9841","authenticated-orcid":true,"given":"Mabel","family":"Chung","sequence":"first","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston (M.C.)."},{"name":"Division of Cardiovascular Medicine, Department of Medicine, Smith Center for Outcomes Research in Cardiology (M.C., Z.I.A., J.X., Y.S., S.J.B., D.S.K., R.W.Y.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5413-6219","authenticated-orcid":true,"given":"Zaid I.","family":"Almarzooq","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Smith Center for Outcomes Research in Cardiology (M.C., Z.I.A., J.X., Y.S., S.J.B., D.S.K., R.W.Y.)"},{"name":"Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA (Z.I.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaman","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Smith Center for Outcomes Research in Cardiology (M.C., Z.I.A., J.X., Y.S., S.J.B., D.S.K., R.W.Y.)"},{"name":"Division of Cardiovascular Medicine, Department of Medicine, (J.X., Y.S., D.S.K., R.W.Y.), Beth Israel Deaconess Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Smith Center for Outcomes Research in Cardiology (M.C., Z.I.A., J.X., Y.S., S.J.B., D.S.K., R.W.Y.)"},{"name":"Division of Cardiovascular Medicine, Department of Medicine, (J.X., Y.S., D.S.K., R.W.Y.), Beth Israel Deaconess Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8319-5637","authenticated-orcid":true,"given":"Suzanne J.","family":"Baron","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Smith Center for Outcomes Research in Cardiology (M.C., Z.I.A., J.X., Y.S., S.J.B., D.S.K., R.W.Y.)"},{"name":"Department of Cardiology, Lahey Hospital and Medical Center, Burlington, MA (S.J.B.)."},{"name":"Baim Institute for Clinical Research, Boston, MA (S.J.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9510-2979","authenticated-orcid":true,"given":"Dhruv S.","family":"Kazi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Smith Center for Outcomes Research in Cardiology (M.C., Z.I.A., J.X., Y.S., S.J.B., D.S.K., R.W.Y.)"},{"name":"Division of Cardiovascular Medicine, Department of Medicine, (J.X., Y.S., D.S.K., R.W.Y.), Beth Israel Deaconess Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0564-4468","authenticated-orcid":true,"given":"Robert W.","family":"Yeh","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Smith Center for Outcomes Research in Cardiology (M.C., Z.I.A., J.X., Y.S., S.J.B., D.S.K., R.W.Y.)"},{"name":"Division of Cardiovascular Medicine, Department of Medicine, (J.X., Y.S., D.S.K., R.W.Y.), Beth Israel Deaconess Medical Center, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816885"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000002701"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15705"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.493320"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.011599"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13484"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2022.10.080"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.4036"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2019.02.007"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046159"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008231"},{"key":"e_1_3_3_13_2","unstructured":"MEDPAC. Ensuring the accuracy and completeness of Medicare advantage encounter data. in. report to the congress: Medicare and the health care delivery system. 2019:205\u2013239."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjdsi.2019.100378"},{"key":"e_1_3_3_15_2","unstructured":"(YNHHSC\/CORE) YNHHSCCfORaE. 2020 Condition-specific excess days in acute care measures updates and specifications report: AMI HF and pneumonia. Accessed September 2 2020. https:\/\/www.qualitynet.org\/files\/5ea97f676a6cce001fbe04d9?filename=2020_EDAC_MU_SpecsReport.pdf"},{"key":"e_1_3_3_16_2","unstructured":"CMS data use agreement. Accessed 10\/26\/2020. https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/sharedsavingsprogram\/Downloads\/Data-Use-Agreement.pdf"}],"container-title":["Circulation: Cardiovascular Quality and Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCOUTCOMES.123.010034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T03:43:37Z","timestamp":1715571817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCOUTCOMES.123.010034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1161\/CIRCOUTCOMES.123.010034"],"URL":"https:\/\/doi.org\/10.1161\/circoutcomes.123.010034","relation":{},"ISSN":["1941-7713","1941-7705"],"issn-type":[{"value":"1941-7713","type":"print"},{"value":"1941-7705","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"2023-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}